Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China · Delayed Price · Currency is CNY 75.73
-2.32 (-2.97%)
Nov 6, 2026, 3:04 PM CST
SHE:300436 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 826.08 | 213.93 | 143.95 | 202.83 | 238.98 | 393.57 |
Cash & Short-Term Investments | 826.08 | 213.93 | 143.95 | 202.83 | 238.98 | 393.57 |
Cash Growth | 236.89% | 48.61% | -29.03% | -15.13% | -39.28% | 189.41% |
Accounts Receivable | 85.16 | 88.95 | 70.43 | 69.76 | 47.97 | 54.26 |
Other Receivables | 7.37 | 28.4 | 28.83 | 25 | 8.21 | 4.94 |
Receivables | 92.53 | 117.35 | 99.26 | 94.76 | 56.18 | 59.2 |
Inventory | 130.68 | 124.85 | 114.48 | 111.48 | 68.66 | 81.8 |
Other Current Assets | 89.31 | 55.29 | 49.61 | 40.22 | 30.48 | 15.32 |
Total Current Assets | 1,139 | 511.42 | 407.3 | 449.29 | 394.3 | 549.89 |
Property, Plant & Equipment | 499.61 | 531.51 | 588.4 | 639.49 | 584.83 | 509.63 |
Long-Term Investments | 70.67 | 73.01 | 80.18 | 108.81 | 170.74 | 99.98 |
Goodwill | 58.97 | 58.97 | 58.97 | 58.97 | 58.97 | 58.97 |
Other Intangible Assets | 144.4 | 162.77 | 251.66 | 292.08 | 100.83 | 118.93 |
Long-Term Deferred Tax Assets | 2.18 | 2.13 | 1.47 | 1.15 | 71.07 | 43.07 |
Long-Term Deferred Charges | 96.33 | 57.87 | 42.78 | 47.75 | 55.22 | 32.56 |
Other Long-Term Assets | 7.7 | 2.8 | 8.06 | 16.94 | 58.87 | 33.74 |
Total Assets | 2,018 | 1,400 | 1,439 | 1,614 | 1,495 | 1,447 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 173.61 | 90.53 | 53.38 | 49.29 | 22.27 | 85.53 |
Accrued Expenses | 11.18 | 117.37 | 174.67 | 175.34 | 89.05 | 38.62 |
Short-Term Debt | 230.37 | 144.15 | 182.18 | 219.18 | 209.27 | 77.76 |
Current Portion of Long-Term Debt | 74.83 | 67.54 | 117.92 | 72.12 | 17.94 | 62.47 |
Current Portion of Leases | - | 0.16 | 0.1 | 0.18 | 0.19 | 0.11 |
Current Income Taxes Payable | 9.11 | 2.27 | 2.91 | 1.67 | 3.8 | 3.77 |
Current Unearned Revenue | 5.1 | 3.88 | 3.57 | 11.91 | 8.22 | 6.63 |
Other Current Liabilities | 45.65 | 46.13 | 40.05 | 68.07 | 57.8 | 27.42 |
Total Current Liabilities | 549.85 | 472.02 | 574.78 | 597.76 | 408.55 | 302.31 |
Long-Term Debt | 178.96 | 244.08 | 142.36 | 167.69 | 84.04 | 47 |
Long-Term Leases | 0.88 | 0.04 | - | 0.09 | 0.1 | - |
Long-Term Unearned Revenue | 52.88 | 60.35 | 65.99 | 39.99 | 42.33 | 45.56 |
Long-Term Deferred Tax Liabilities | 2.13 | 2.1 | 2.67 | 2.38 | 2.42 | 2.05 |
Other Long-Term Liabilities | 291.67 | 275.59 | 256.24 | 237.31 | 1.79 | - |
Total Liabilities | 1,076 | 1,054 | 1,042 | 1,045 | 539.22 | 396.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 168.03 | 159.27 | 159.27 | 159.27 | 159.27 | 158.78 |
Additional Paid-In Capital | 1,379 | 743.12 | 607.93 | 607.93 | 671.32 | 659.29 |
Retained Earnings | -728.42 | -624.86 | -407.01 | -250.71 | 97.88 | 225.28 |
Total Common Equity | 818.71 | 277.53 | 360.18 | 516.48 | 928.46 | 1,043 |
Minority Interest | 123.38 | 68.77 | 36.6 | 52.76 | 27.16 | 6.49 |
Shareholders' Equity | 942.08 | 346.3 | 396.78 | 569.24 | 955.62 | 1,050 |
Total Liabilities & Equity | 2,018 | 1,400 | 1,439 | 1,614 | 1,495 | 1,447 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | 485.04 | 455.97 | 442.56 | 459.27 | 311.55 | 187.33 |
Net Cash (Debt) | 341.04 | -242.03 | -298.6 | -256.44 | -72.57 | 206.24 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 2.13 | -1.52 | -1.87 | -1.61 | -0.46 | 1.38 |
Filing Date Shares Outstanding | 162.14 | 159.27 | 159.27 | 159.27 | 159.27 | 158.78 |
Total Common Shares Outstanding | 162.14 | 159.27 | 159.27 | 159.27 | 159.27 | 158.78 |
Working Capital | 588.75 | 39.4 | -167.48 | -148.48 | -14.25 | 247.58 |
Book Value Per Share | 5.05 | 1.74 | 2.26 | 3.24 | 5.83 | 6.57 |
Tangible Book Value | 615.34 | 55.79 | 49.56 | 165.44 | 768.66 | 865.45 |
Tangible Book Value Per Share | 3.80 | 0.35 | 0.31 | 1.04 | 4.83 | 5.45 |
Buildings | - | 557.06 | 561.67 | 565.02 | 536.94 | 397.03 |
Machinery | - | 271.69 | 271.55 | 268.43 | 179.92 | 116.23 |
Construction In Progress | - | 21.7 | 29.76 | 29.86 | 50.6 | 147.22 |